跳到正文

Lynx1 Capital Management LP 内部人交易:近期 SEC Form 4 交易

过去 18 个月,Lynx1 Capital Management LP(CIK 1910456)在 5 家公司共报告 26 笔 SEC Form 4 内部人交易(最近一笔 2026-10-26)。

日期公司身份类型股数市值
2026-10-26Korro Bio, Inc. (KRRO)10% 以上股东买入40,000$441,464
2026-10-26Korro Bio, Inc. (KRRO)10% 以上股东买入2,510$30,386
2026-10-26Korro Bio, Inc. (KRRO)10% 以上股东买入25,124$295,091
2026-10-26Korro Bio, Inc. (KRRO)10% 以上股东买入12,175$117,810
2026-08-13Korro Bio, Inc. (KRRO)10% 以上股东买入5,222$59,531
2026-08-13Korro Bio, Inc. (KRRO)10% 以上股东买入1,462$19,284
2026-06-29Passage BIO, Inc. (PASG)10% 以上股东买入50,055$206,227
2026-04-02Korro Bio, Inc. (KRRO)10% 以上股东买入520$5,512
2025-12-23TScan Therapeutics, Inc. (TCRX)10% 以上股东买入75,500$67,950
2025-12-23TScan Therapeutics, Inc. (TCRX)10% 以上股东买入80,069$72,062
2025-12-23TScan Therapeutics, Inc. (TCRX)10% 以上股东买入6,232$5,609
2025-10-30Cullinan Therapeutics, Inc. (CGEM)10% 以上股东买入165,667$1.4M
2025-10-23Neuphoria Therapeutics Inc. (NEUP)10% 以上股东买入639,110$3.3M
2025-10-21Cullinan Therapeutics, Inc. (CGEM)10% 以上股东买入15,032$114,093
2025-10-21Cullinan Therapeutics, Inc. (CGEM)10% 以上股东买入51,500$408,910
2025-10-21Cullinan Therapeutics, Inc. (CGEM)10% 以上股东买入150,000$1.3M
2025-10-21Cullinan Therapeutics, Inc. (CGEM)10% 以上股东买入32,217$252,581
2025-10-10Cullinan Therapeutics, Inc. (CGEM)10% 以上股东买入556,300$3.6M
2025-10-10Cullinan Therapeutics, Inc. (CGEM)10% 以上股东买入626,043$4.2M
2025-10-10Cullinan Therapeutics, Inc. (CGEM)10% 以上股东买入277,298$2.0M
2025-09-15Passage BIO, Inc. (PASG)10% 以上股东买入325$2,262
2025-09-15Passage BIO, Inc. (PASG)10% 以上股东买入19,783$138,283
2025-09-15Passage BIO, Inc. (PASG)10% 以上股东买入11,900$83,181
2025-07-24Passage BIO, Inc. (PASG)10% 以上股东买入13,123$71,389
2025-07-24Passage BIO, Inc. (PASG)10% 以上股东买入49,302$282,993

来源:SEC Form 4 申报文件 · 截至 2026-10-26